Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27
+0.82002.03%
Post-market: 41.270.00000.00%18:39 EDT
Volume:1.26M
Turnover:52.12M
Market Cap:1.06B
PE:- -
High:41.37
Open:40.60
Low:40.60
Close:40.45
52wk High:43.52
52wk Low:28.77
Shares:25.80M
Float Shares:25.80M
Volume Ratio:15.04
T/O Rate:4.90%
Dividend:0.29
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Oct 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 09

Johnson & Johnson reports new two-year results from Phase 3 ICONIC-LEAD study

TIPRANKS
·
Oct 09

J&J Says Phase 3 Iconic-LEAD Trial Shows Icotyde Sustains Plaque Psoriasis Clearance Through 2 Years

Reuters
·
Oct 09

J&J - at Week 112, 72% Achieve Pasi 90, 70% Achieve Iga 0/1 with Icotyde

THOMSON REUTERS
·
Oct 09

J&J - no New Safety Signals Identified for Icotyde Through Week 112

THOMSON REUTERS
·
Oct 09

New Johnson & Johnson Icotyde® (Icotrokinra) Long-Term Data Demonstrate Robust 2-Year Results in the Treatment of Adults and Adolescents with Plaque Psoriasis

THOMSON REUTERS
·
Oct 09

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Oct 09

Merck price target lowered to $163 from $166 at BofA

TIPRANKS
·
Oct 09

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Oct 09

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Oct 09

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Oct 09

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Oct 09

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Oct 09

Wells Fargo Adjusts Price Target on Merck & Co to $165 From $170

MT Newswires Live
·
Oct 09

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
Oct 09

What Do Johnson & Johnson (JNJ) Trial Wins Mean For Its Drug Pipeline?

Simply Wall St.
·
Oct 09

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 09

Lilly’s Oral Orforglipron Trial Targets Early Obesity Risks, Raising the Stakes in Weight-Loss Pharma

TIPRANKS
·
Oct 09

AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study

TIPRANKS
·
Oct 09